AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Harvest Technology Group Ltd

0.019

+0.0015.56%

Volume:939.87K

Turnover:17.32K

Market Cap:20.55M

PE:-2.31

High:0.019

Open:0.018

Low:0.017

Close:0.018

52wk High:0.027

52wk Low:0.012

Shares:1.08B

Float Shares:596.77M

Volume Ratio:1.44

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.008

ROE:-119.06%

ROA:-87.04%

PB:-1.91

PE(LYR):-2.31

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Harvest Technology Executes Exclusive Reseller Agreement With Pyxis Controls

Harvest Technology - Pyxis Has Been Granted Exclusive Regional Rights to Represent Harvest's Nodestream™ Solutions Across Menatisa Region

THOMSON REUTERS

Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions

Harvest Technology Group Ltd-Proposed Issue of Securities - Htg

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HTG.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HTG.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HTG.AU\",,,,,undefined,":{"symbol":"HTG.AU","market":"AU","secType":"STK","nameCN":"Harvest Technology Group Ltd","latestPrice":0.019,"timestamp":1770354720000,"preClose":0.018,"halted":0,"volume":939873,"delay":0,"changeRate":0.05555555555555561,"nameEN":"Harvest Technology Group Ltd","floatShares":596770884,"shares":1081723517,"eps":-0.008238,"marketStatus":"Market Closed","change":0.001,"latestTime":"02-06 16:12:00 AEDT","open":0.018,"high":0.019,"low":0.017,"amount":17323,"amplitude":0.111111,"askPrice":0.02,"askSize":321500,"bidPrice":0.018,"bidSize":138888,"shortable":3,"etf":0,"ttmEps":-0.008238,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.018,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":1.440559245309741,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HTG.AU\",,,,,undefined,":{"symbol":"HTG.AU","floatShares":596770884,"roa":"-87.04%","roe":"-119.06%","lyrEps":-0.008238,"volumeRatio":1.440559245309741,"shares":1081723517,"dividePrice":0,"high":0.019,"amplitude":0.111111,"preClose":0.018,"low":0.017,"week52Low":0.012,"pbRate":"-1.91","psRate":"5.03","week52High":0.027,"institutionHeld":0,"latestPrice":0.019,"committee":-0.396648,"eps":-0.008238,"divideRate":0,"volume":939873,"delay":0,"ttmEps":-0.008238,"open":0.018,"prevYearClose":0.018,"prevWeekClose":0.017,"prevMonthClose":0.017,"prevQuarterClose":0.018,"fiveDayClose":0.017,"twentyDayClose":0.019,"sixtyDayClose":0.018,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HTG.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2021-12-15","symbol":"HTG.AU","defaultRemindTime":1639522800000,"type":"split","dateTimestamp":1639486800000,"forFactor":992094,"toFactor":1000000,"ratio":0.992094}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HTG.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HTG.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584606162","title":"BRIEF-Harvest Technology Executes Exclusive Reseller Agreement With Pyxis Controls","url":"https://stock-news.laohu8.com/highlight/detail?id=2584606162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584606162?lang=en_us&edition=fundamental","pubTime":"2025-11-18 09:12","pubTimestamp":1763428370,"startTime":"0","endTime":"0","summary":"BRIEF-Harvest Technology Executes Exclusive Reseller Agreement With Pyxis ControlsNov 18  - Harvest Technology Group Ltd HTG.AX:HARVEST EXECUTES EXCLUSIVE RESELLER AGREEMENT WITH PYXIS CONTROLSPYXIS HAS BEEN GRANTED EXCLUSIVE REGIONAL RIGHTS TO REPRESENT HARVEST'S NODESTREAM SOLUTIONS ACROSS MENATISA REGIONFurther company coverage: HTG.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nFWN3WT1D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7016","HTG.AU","BK7084"],"gpt_icon":0},{"id":"2584674184","title":"Harvest Technology - Pyxis Has Been Granted Exclusive Regional Rights to Represent Harvest's Nodestream™ Solutions Across Menatisa Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2584674184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584674184?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:28","pubTimestamp":1763414909,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nFWN3WT1D6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7016","HTG.AU","BK7084"],"gpt_icon":0},{"id":"2582826846","title":"Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2582826846","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582826846?lang=en_us&edition=fundamental","pubTime":"2025-11-10 12:00","pubTimestamp":1762747200,"startTime":"0","endTime":"0","summary":"The randomized, placebo-controlled Single Ascending Dose  study in volunteers with baseline TG >80 mg/dl showed favorable tolerability, no serious adverse events, with mild, self-limited injection-site reactions  and transient ALT and AST elevations typical of GalNAc-conjugated siRNAs. RN0361 demonstrated dose-responsive suppression of both ApoC3 and TG through Day 180, with a maximum 93% ApoC3 reduction and 69% triglyceride lowering. RN0361 also robustly reduced atherogenic lipoproteins, non-HDL-c, VLDL cholesterol and remnant cholesterol. No changes in fasting glucose or HbA1c were observed versus placebo.Elevated ApoC3 drives triglyceride-rich lipoprotein accumulation, increasing risks of acute pancreatitis and cardiovascular disease, particularly in diabetes. Current therapies often fail to achieve sustained control in severe cases. RN0361's profound, six-month efficacy from a single dose may address this unmet need and marks a significant advance in lipid management.Rona Therapeut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/rona-therapeutics-presents-phase-1-data-for-rn0361-a-long-acting-apoc3-targeting-sirna-at-the-american-heart-association-2025-scientific-sessions-302609497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TG","BK4139","AFG","BK7084","BK7016","LENZ","BK4539","BK4153","BK4090","HTG.AU","BK4107","BK4117"],"gpt_icon":0},{"id":"2578672043","title":"Harvest Technology Group Ltd-Proposed Issue of Securities - Htg","url":"https://stock-news.laohu8.com/highlight/detail?id=2578672043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578672043?lang=en_us&edition=fundamental","pubTime":"2025-10-28 06:59","pubTimestamp":1761605974,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUE1RMP8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7016","BK7084","HTG.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HTG.AU\",params:#limit:6,delay:true,,,undefined,":[]}}